Status:
COMPLETED
Drug Use Investigation for REVOLADE (ITP)
Lead Sponsor:
Novartis Pharmaceuticals
Conditions:
Purpura, Thrombocytopaenic, Idiopathic
Eligibility:
All Genders
Brief Summary
To investigate safety and efficacy in the actual use of REVOLADE collected from all subjects receiving the drug until data from a specified number of subjects are accumulated to identify factors consi...
Eligibility Criteria
Inclusion
- Subjects with chronic idiopathic thrombocytopenic purpura
Exclusion
- Not applicable
Key Trial Info
Start Date :
December 21 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 16 2020
Estimated Enrollment :
5797 Patients enrolled
Trial Details
Trial ID
NCT01416311
Start Date
December 21 2010
End Date
October 16 2020
Last Update
November 20 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.